Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiplasmin activity of electrophoretically separated human serum fractions.

Literature DB >> 4160096

Antiplasmin activity of electrophoretically separated human serum fractions.

Abstract

The antiplasmin which migrates electrophoretically with the alpha(2) globulins preponderates in effect over that of the alpha(1) migrating antiplasmin. This preponderance persists at physiological pH value in vitro and the significance of this finding is discussed. No evidence has been obtained of the existence of anti-urokinase activity in antiplasmin-free serum fractions.

Entities: Gene Species

Mesh：

Substances：

Year: 1966 PMID： 4160096 PMCID： PMC473229 DOI： 10.1136/jcp.19.2.185

Source DB: PubMed Journal: J Clin Pathol ISSN： 0021-9746 Impact factor: 3.411

12 in total

1. FRACTIONATION AND CHARACTERIZATION OF AN INHIBITOR OF PLASMIN FOUND IN NORMAL PLASMA.

Authors: F B TAYLOR; L W ALLEN; A F BICKFORD
Journal: Arch Biochem Biophys Date: 1964-02 Impact factor: 4.013

2. ANTIPLASMIN ACTIVITY OF BETA-LIPOPROTEIN.

Authors: I M RIDING; D ELLIS
Journal: J Atheroscler Res Date: 1964 Mar-Apr

3. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.

Authors: C M AMBRUS; G MARKUS
Journal: Am J Physiol Date: 1960-09

4. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.

Authors: L B NANNINGA; M M GUEST
Journal: Arch Biochem Biophys Date: 1964-12 Impact factor: 4.013

5. A study of the plasmin-inhibitor reaction.

Authors: M RYBAK
Journal: Physiol Bohemoslov Date: 1962

6. Pathophysiology of plasmin system. II. Fibrinolysis and plasmin (activator)--inhibitor ratio.

Authors: M MAKI; K NAGASAWA
Journal: Tohoku J Exp Med Date: 1963-01-25 Impact factor: 1.848

7. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system.

Authors: I M NILSSON; H KROOK; N H STERNBY; E SODERBERG; N SODERSTROM
Journal: Acta Med Scand Date: 1961-03

Antiplasmin activity of electrophoretically separated human serum fractions.

1. FRACTIONATION AND CHARACTERIZATION OF AN INHIBITOR OF PLASMIN FOUND IN NORMAL PLASMA.

2. ANTIPLASMIN ACTIVITY OF BETA-LIPOPROTEIN.

3. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.

4. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.

5. A study of the plasmin-inhibitor reaction.

6. Pathophysiology of plasmin system. II. Fibrinolysis and plasmin (activator)--inhibitor ratio.

7. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system.

8. Fibrinolysis by adsorption.

9. Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma.

10. Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.

1. Intraglomerular fibrin, platelet aggregation, and subendothelial deposits in lipoid nephrosis.